4//SEC Filing
Gold Lawrence Marshall 4
Accession 0001213900-21-013754
CIK 0001690080other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:31 PM ET
Size
5.1 KB
Accession
0001213900-21-013754
Insider Transaction Report
Form 4
Gold Lawrence Marshall
Director
Transactions
- Award
Common Stock
2021-03-04$3.94/sh+2,101$8,278→ 2,101 total
Footnotes (1)
- [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for a portion of the quarter ended December 31, 2020. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001355868
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:31 PM ET
- Size
- 5.1 KB